MADRIGAL PHARMACEUTICALS, INC. (MDGL) Most Active Options

The 25 most actively traded MADRIGAL PHARMACEUTICALS, INC. (MDGL) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Oct 9, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$471.85
52-week range
$412.91 – $612.00
ATM IV (30d)
34.8%
IV rank
26 / 100
Low
Expected move
±$22.77 (±4.8%)
Put/call OI
0.29
Call-heavy
Max pain
$480
↑ 1.7% above close
Next earnings
Nov 3, 2026

Chat with OptAI about MDGL


Most Active MDGL Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
MDGL $540 call Dec 18, 2026 67d $18.50 53.2% 48 0.31 650 200 116.7× avg
MDGL $500 call Nov 20, 2026 39d $22.17 57.5% 65 0.40 8 8 0.9× avg
MDGL $480 call Oct 16, 2026 4d $7.50 55.1% 9 0.33 25 8 7.2× avg
MDGL $610 call Jan 15, 2027 95d $11.30 48.9% 18 0.18 7 7 22.4× avg
MDGL $490 put Oct 16, 2026 4d $24.70 51.7% 100 -0.80 30 6 10.0× avg
MDGL $700 call Dec 17, 2027 431d $49.90 50.9% 63 0.36 265 6 4.1× avg
MDGL $490 put Nov 20, 2026 39d $45.60 56.5% 100 -0.56 5 6 10.5× avg
MDGL $430 put Nov 20, 2026 39d $17.18 58.3% 99 -0.29 5 5 2.2× avg
MDGL $450 put Oct 16, 2026 4d $4.10 56.1% 5 -0.25 23 5 1.0× avg
MDGL $440 put Nov 20, 2026 39d $21.58 57.0% 100 -0.33 9 5 2.2× avg
MDGL $600 call Mar 19, 2027 158d $25.00 53.2% 60 0.31 11 3 9.6× avg
MDGL $500 put Oct 16, 2026 4d $37.31 48.3% 44 -0.90 191 3 18.0× avg
MDGL $460 put Oct 16, 2026 4d $8.00 49.3% 35 -0.37 123 3 3.0× avg
MDGL $550 call Jan 15, 2027 95d $19.50 49.2% 0 0.31 33 3 5.4× avg
MDGL $580 call Oct 16, 2026 4d $0.12 128.8% 18 0.06 35 2 4.0× avg
MDGL $470 call Dec 17, 2027 431d $116.00 55.1% 0 0.64 3 2 7.5× avg
MDGL $380 put Nov 20, 2026 39d $5.00 59.9% 50 -0.12 1 2 2.9× avg
MDGL $720 put Jan 15, 2027 95d $254.90 62.5% — -0.88 0 2 —
MDGL $600 call Jan 15, 2027 95d $11.30 48.9% 17 0.20 80 2 6.4× avg
MDGL $350 put Mar 19, 2027 158d $17.80 58.5% — -0.16 5 1 —
MDGL $760 call Dec 17, 2027 431d $39.20 50.7% — 0.30 100 1 —
MDGL $470 call Oct 16, 2026 4d $9.40 56.1% 54 0.47 14 1 0.6× avg
MDGL $450 put Dec 17, 2027 431d $83.90 54.7% 76 -0.33 59 1 3.3× avg
MDGL $540 call Oct 16, 2026 4d $0.80 84.0% 46 0.05 9 1 0.2× avg
MDGL $570 call Oct 16, 2026 4d $0.05 133.9% 18 0.09 25 1 2.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active MDGL contract today is the $540 call expiring in 67 days, with 200 contracts traded. Calls dominate the most-active list (14 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on MDGL for free

Build multi-leg MDGL strategies, visualize payoffs, and scan the full US options universe with OptiView.

MDGL Options FAQ

Which MDGL option contract is most active today?

The most traded MDGL contract is the $540 call expiring Dec 18, 2026, with 200 contracts traded as of Oct 9, 2026.

How does OptiView rank the most active MDGL options?

The table lists the 25 MDGL contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.